Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer

British Journal of Cancer

Volumn 83, Issue 10, 2000, Pages 1344-1350

  Renehan, A G ^a   Jones, J ^b   Potten, C S ^a   Shalet, S M ^a   O'Dwyer, S T ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Binding proteins; Colorectal cancer; IGF II

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR VOLUME;

EID: 0033750859     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1462     Document Type: Article

References (45)

1. Type I insulin-like growth factor receptors in human colorectal cancer
2. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix
3. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: Possible association with the metastatic potential of the tumor
4. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
5. Insulin-like growth factor binding proteins and their role in controlling IGF actions
6. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients
7. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer
8. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
9. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2
10. Malnutrition and food intake in relation to quality of life in head and neck cancer patients
11. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
12. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
13. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines
14. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorogenic potential in Y-1 adrenocortical tumor cells
15. Insulin-like growth factors and their binding proteins: Biological actions
16. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
17. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid
18. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: Correlation with tumor progression, proliferative activity and survival
19. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
20. Insulin-like growth factor II in two human colon-carcinoma cell lines: Gene structure and expression, and protein secretion
21. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors
22. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
23. Insulin-like growth factors and cancer
24. IGF-I and IGF-II in relation to colorectal cancer
25. Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers
26. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer
27. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia
28. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia
29. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
30. Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours
31. Surveillance after colorectal cancer resection
32. Circulating insulin-like growth factor (IGF)-II and colorectal adenomas
33. 'High-risk' colorectal adenomas and serum insulin-like growth factors
34. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: Role of IGF-II
35. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-1 inhibitory bioactivity in adolescent insulin-dependent diabetics
36. Nutritional regulation of the insulin-like growth factors
37. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease
38. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas
39. Cancer of the colon: The influence of the no-touch technique on survival rates
40. Value of carcinoembryonic antigen in the management of colorectal cancer
41. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone
42. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer
43. Insulin-like growth factors (IGF-I, Free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
44. Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour